Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-9.55%
2023-1.37%
2022-3.56%
2021460.94%
202043.20%
20190.00%